| Aug 20 |
Hims & Hers Health: Healthy Gift
|
| Aug 20 |
Hims & Hers: Great Value Amid Unwarranted Concerns (Rating Upgrade)
|
| Aug 20 |
Hims & Hers: Digesting Q2 2024 Earnings, Shares Still Undervalued, Rating Downgrade
|
| Aug 20 |
Top 3 Growth Stocks With High Insider Ownership And Up To 40% Earnings Growth
|
| Aug 19 |
Telehealth Firm Hims & Hers Health Rides High On Demand for Copycat Weight Loss Drugs Amid Supply Shortages
|
| Aug 11 |
What Eli Lilly, Novo Nordisk earnings reveal about the future of GLP-1 sales
|
| Aug 10 |
Bullish: Analysts Just Made A Neat Upgrade To Their Hims & Hers Health, Inc. (NYSE:HIMS) Forecasts
|
| Aug 7 |
Hims & Hers Health: Buy The Dip, With Or Without The GLP-1 Shortage
|
| Aug 7 |
Hims & Hers Health Second Quarter 2024 Earnings: Beats Expectations
|
| Aug 6 |
Hims & Hers Health down 4% in volatile trading following quarterly earnings
|
